LTS Our Team

OUR TEAM

LTS Our TeamLTS Our Team

OUR TEAM

Leadership Team

Sebastiaan M. van Buijtenen
Sebastiaan M. van BuijtenenChairman of the Executive Board

Watch our Video-Interview with Bas van Buijtenen, CEO and Chair of the Executive Board at LTS. We start by discussing the LTS response to the pandemic, before reviewing the growing impact of MAP as a delivery mechanism, before ending with Bas van Buijtenen’s predictions for 2022 – expansion in capabilities and extension in therapy areas served.

Ulrich Sielaff
Ulrich SielaffChief Financial Officer
Dr. Claudia Schaefer
Dr. Claudia SchaeferChief Operating Officer

Watch our Video-Interview with Dr. Claudia Schaefer on YouTube as she discusses continuous improvement in efficacy, quality, and people utilization.

Dr. Detlev Radloff
Dr. Detlev RadloffPresident LTS EMEA/A Pharma Products
Jeremy Ordemann
Jeremy OrdemannPresident LTS North America Pharma Products
Dr. Andrei Yosef
Dr. Andrei Yosef President and General Manager Device Technologies
Dave Doles
Dave DolesPresident Nasal & Sterile Drug Products
Julie Simon
Julie SimonSVP Strategy and Commercial Excellence
Dr. Hanshermann Franke
Dr. Hanshermann FrankeSVP R&D Pharma Products

Watch our Video-Interview with Dr. Hanshermann Franke on YouTube as he discusses the R&D journey of LTS to date.

Alexander Becker
Alexander BeckerSVP Head of Finance, Accounting and Controlling Pharma Products
Barak Dvir
Barak DvirSVP Finance & Bus. Services Device Technologies
Justin Cano
Justin CanoSVP Finance and Business Services Nasal & Sterile Drug Products

Find your Business Development contact here!

Supervisory Board

  • Dr. Ellen de Brabander (Chair of the supervisory board)

  • Dr. Michael Hoffmann
  • Rüdiger Busley

  • Anja Brühl

  • Michael Mildner